Tarsus Pharmaceuticals, Inc. Operating Lease, Liability, Noncurrent in USD from Q4 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Tarsus Pharmaceuticals, Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q4 2019 to Q3 2025.
  • Tarsus Pharmaceuticals, Inc. Operating Lease, Liability, Noncurrent for the quarter ending September 30, 2025 was $10.1M, a 718% increase year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)

Tarsus Pharmaceuticals, Inc. Quarterly Operating Lease, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $10.1M +$8.91M +718% Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $0 -$1.45M -100% Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $0 -$1.61M -100% Mar 31, 2025 10-Q 2025-05-01
Q4 2024 $0 -$1.52M -100% Dec 31, 2024 10-K 2025-02-25
Q3 2024 $1.24M -$426K -25.6% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.45M -$366K -20.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.61M Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.52M +$1.46M +2813% Dec 31, 2023 10-K 2024-02-27
Q3 2023 $1.67M +$1.5M +886% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.82M +$1.52M +505% Jun 30, 2023 10-Q 2023-08-10
Q4 2022 $52K -$533K -91.1% Dec 31, 2022 10-K 2023-03-17
Q3 2022 $169K -$586K -77.6% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $300K -$105K -25.9% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $425K -$31K -6.8% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $585K +$36K +6.56% Dec 31, 2021 10-K 2023-03-17
Q3 2021 $755K +$130K +20.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $405K Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $456K Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $549K +$449K +449% Dec 31, 2020 10-K 2022-03-14
Q3 2020 $625K Sep 30, 2020 10-Q 2020-11-25
Q4 2019 $100K Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.